Abbott (ABT) Tops Q3 EPS by 8c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Abbott Labs (ABT) PT Raised to $113 at Cowen Into Q3 Results
October 19, 2020 5:48 PM EDTCowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $113.00 (from $105.00) while maintaining an Outperform rating ahead of Q3 results.
The analyst commented, "Ahead of ABT's 3Q report on October 21, we're raising our 2H'20 forecasts to better... More
